Englander Institute for Precision Medicine
Found 869 results
Author Title Type [ Year(Asc)]
Filters: Corrigendum-whole-genome-and-transcriptome-analysis-pancreatic-acinar-cell-carcinoma is   [Clear All Filters]
2026
Xu C, Xu J, Bulusu KC, Pan H, Elemento O.  2026.  BEACON: predicting side effects and therapeutics outcomes to drugs by Bridging knowlEdge grAph with CONtextual language model.. bioRxiv.
Mak L, Tierney B, Wei W, Ronkowski C, Toscan RBrizola, Turhan B, Toomey M, Andrade-Martinez JSebastian, Fu C, Lucaci AG et al..  2026.  CAMP: a modular metagenomics analysis system for integrated multistep data exploration.. NAR Genom Bioinform. 8(1):lqaf172.
Agarwal PK, Sternberg CN.  2026.  Clinical trials corner issue 12(1).. Bladder Cancer. 12(1):23523735261424951.
Kaza S, Mohanty AS, Serpedin A, Yau J, Kim YEun, Kutler RB, Elemento O, Sulica L, Khosravi P, Rameau A.  2026.  Exploring Real-Time Tracking of Vocal Fold Polyps in Video-Stroboscopy Using Deep Learning.. Laryngoscope.
Stephan N, Halama A, Thareja G, Sarwath H, Grallert H, Peters A, Gieger C, Schmidt F, Graumann J, Suhre K.  2026.  Identification of Protein Signatures Reflecting Latent Variation in Aptamer-Based Affinity Proteomics.. J Proteome Res.
Toth R, Choi S, Le Naour-Vernet M, Schwanke F, Johnson JL, Tee EE, Yaron-Barir TM, Khochaba E, Derbyshire P, Colo A et al..  2026.  Motif-based substrate mapping of the receptor-like cytoplasmic kinase BIK1 reveals novel components and regulatory nodes of plant immunity.. Nat Plants. 12(2):465-480.
Surapaneni S, Kutler RB, Setzen SA, Kim YEun, Yao P, Siddiqui SH, Pitman MJ, Sulica L, Elemento O, Khosravi P et al..  2026.  A Multimodal Approach for Deep-Learning Classification of Vocal Fold Pathologies in Stroboscopy.. Laryngoscope.
Xu C, Us I, Cohen-Setton J, Milo M, Sidders B, Fitzgibbon J, Melnick AM, Pan H, Bulusu KC, Elemento O.  2026.  PAIRWISE: Deep Learning-based Prediction of Effective Personalized Drug Combinations in Cancer.. Res Sq.
Xing Y, Reznikov I, Ahmed ANur, Sidhu I, Wisnewski J, Farhat A, Prystupa A, Konieczny P, Mansfield K, Cooper ML et al..  2026.  Peripheral immune-inducer dendritic cells drive early-life allergic inflammation.. Nature.
De Boni L, Claridge S, Nath S, Tofani K, Stein BD, Park E, Steiner S, Elemento O, Pauli C, Hopkins BD.  2026.  Placing purines in precision medicine: Targeting a metabolic reliance in KRAS-mutant tumors.. iScience. 29(3):114954.
Nazzaro M, Mardis ER, Canella A, Bhinder B, Elemento O, Behbehani G, Currier M, Glaspell A, Lee DA, Cripe TP et al..  2026.  Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progression.. Mol Ther Oncol. 34(1):201147.
Armstrong AJ, Morris MJ, Abida W, Aggarwal RR, Antonarakis ES, Attard G, Beltran H, Bryce A, Carducci MA, Cheng HH et al..  2026.  Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.. J Clin Oncol. :JCO2502834.
Purkayastha S, Park J, Beyer S, Chandra A, Markowitz SM, Lerman BB, Elemento O, Krumsiek J, Lo JC, Cheung JW.  2026.  Utilization of Serum Metabolomics and Polygenic Risk Scores in a Novel Risk Stratification Tool for the Prediction of Incident Atrial Fibrillation.. Circ Arrhythm Electrophysiol. :e013858.
Assaad MAl, Hadi K, Levine MF, Guevara D, Patel M, Tranquille M, King A, Otilano J, Semaan A, Gundem G et al..  2026.  Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort.. Commun Med (Lond). 6(1):5.
2025
Yoffe L, Bhinder B, Kang SWook, Zhang H, Singh A, Ravichandran H, Markowitz G, Martin M, Kim J, Zhang C et al..  2025.  Acquisition of discrete immune suppressive barriers contributes to the initiation and progression of preinvasive to invasive human lung cancer.. bioRxiv.
Setzen SA, Andreadis K, Elemento O, Rameau A.  2025.  AI-Powered Laryngoscopy: Exploring the Future With Google Gemini.. Laryngoscope.
Bose A, Liu W, Yoo P, Sami A, Boniecki MT, Deshpande M, Osman M, Nguyen D, Castillo UD, Giannakakou P et al..  2025.  APOBEC3A-Induced DNA Damage Drives Polymerase θ Dependency and Synthetic Lethality in Cancer.. bioRxiv.
O'Boyle B, Yeung W, Lu JD, Katiyar S, Yaron-Barir TM, Johnson JL, Cantley LC, Kannan N.  2025.  An atlas of bacterial serine-threonine kinases reveals functional diversity and key distinctions from eukaryotic kinases.. Sci Signal. 18(885):eadt8686.
Gao VR, Yang R, Das A, Luo R, Luo H, McNally DR, Karagiannidis I, Rivas MA, Wang Z-M, Barisic D et al..  2025.  Author Correction: ChromaFold predicts the 3D contact map from single-cell chromatin accessibility.. Nat Commun. 16(1):684.
Petroni G, Galassi C, Gouin KH, Chen H-H, Buqué A, Bloy N, Yamazaki T, Sato A, Beltrán-Visiedo M, Campia G et al..  2025.  Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.. Nat Cancer.
Khosravi P, Saikali S, Alipour A, Mohammadi S, Boger M, Diallo DM, Smith CJ, Moschovas MC, Hajirasouliha I, Hung AJ et al..  2025.  AutoRadAI: a versatile artificial intelligence framework validated for detecting extracapsular extension in prostate cancer.. Biol Methods Protoc. 10(1):bpaf032.
Bellmunt J, Powles T, Park SHoon, Voog E, Valderrama BP, Gurney H, Ullén A, Loriot Y, Sridhar SS, Tsuchiya N et al..  2025.  Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Outcomes from the JAVELIN Bladder 100 Trial in Patients with Nonvisceral or Lymph Node-only Disease.. Eur Urol.
Meleshko D, Yang R, Maharjan S, Danko DC, Korobeynikov A, Hajirasouliha I.  2025.  Blackbird: structural variant detection using synthetic and low-coverage long-reads.. Bioinform Adv. 5(1):vbaf151.
Powles T, Sridhar SS, Bellmunt J, Sternberg CN, Grivas P, Hunter E, Salter M, Powell R, Dring A, Green J et al..  2025.  Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100.. Cancers (Basel). 17(14)
Moothedan E, Boyer M, Watts S, Abdel-Aty Y, Ghosh S, Rameau A, Sigaras A, Elemento O, Bensoussan Y.  2025.  The Bridge2AI-voice application: initial feasibility study of voice data acquisition through mobile health.. Front Digit Health. 7:1514971.